Lcz696 CAS 936623-90-4

China Lcz696 CAS 936623-90-4, Find details about China Lcz696 78755-81-4, 78755-81-4 Lcz696 from Lcz696 CAS 936623-90-4

Basic Info.

Model NO.

FS 936623-90-4

Storage Condition

Store at Rt

Colour

White

Trademark

FOUSI

Transport Package

Aluminum Foil Bag

Origin

China

Model NO.

FS 936623-90-4

Storage Condition

Store at Rt

Colour

White

Trademark

FOUSI

Transport Package

Aluminum Foil Bag

Origin

China

Product Desciption

LCZ696 CAS 936623-90-4

LCZ696 is a drug developed by Novartis Pharmaceuticals in the United States to treat heart failure. Heart failure is a life-threatening disease. The patient's heart cannot pump enough blood to supply the whole body, and symptoms such as dyspnea, fatigue and fluid retention can slowly appear and gradually worsen, which obviously affects the quality of life.

Lcz696 CAS 936623-90-4

Product Name	LCZ696
MF	C48H58N6O8
EINECS	000-000-0
Related categories	Used for treating patients with heart failure. ; Inhibitor; Medical anti-heart failure drugs; Anti-tumor; Cell biology reagent; Medical raw materials; Chemical intermediates; Small molecule inhibitor, natural product; API; Keywords new drug, enkephalinase inhibitor, API; Small molecule inhibitor; Inhibitors; Pharmaceutical raw materials; CardiovascularSeries; Medical raw materials; Medical raw materials

Application of Tryptamine:

LCZ696 is a double-acting angiotensin receptor enkephalinase inhibitors, which has a unique mode of action and is considered to reduce the strain of the failing heart. LCZ696 can enhance the body's natural defense against heart failure, increase the level of natriuretic peptide and other endogenous vasoactive peptides, and inhibit renin-angiotensin-aldosterone system (RAAS).

Lcz696 CAS 936623-90-4